Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Tumor Cell Count”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT02032368
What this trial is testing

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Who this might be right for
Circulating Tumor Cell;Hepatocellular Carcinoma
Guangdong Provincial People's Hospital 57
Not applicableLooking for participantsNCT07296250
What this trial is testing

Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT

Who this might be right for
Head and Neck CancerOral Cancer
Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT03070002
What this trial is testing

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Who this might be right for
Breast Carcinoma Metastatic in the BoneCirculating Tumor Cell CountEstrogen Receptor Positive+3 more
Northwestern University 1
Not applicableStudy completedNCT05793775
What this trial is testing

Circulating Tumor Cells and Neutrophils Count for Colorectal Metastatic Cancer

Who this might be right for
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Nice 30
Not applicableLooking for participantsNCT04087473
What this trial is testing

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

Who this might be right for
Non-small Cell Lung CancerALK-Positive Lung Cancer
National Cancer Centre, Singapore 50
Early research (Phase 1)Study completedNCT02552394
What this trial is testing

J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 10